Related Experiment Video
Updated: Aug 6, 2026

05:02
Establishment of Acute Pontine Infarction in Rats by Electrical Stimulation
Published on: August 27, 2020
[Central pontine myelinolysis--case report]
Małgorzata Gałka1, Wiesław Chudzik, Henryk Chmielewski
1Uniwersytet Medyczny w Lodzi, Klinika Neurologii i Neurorehabilitacji, Oddział Udarowy Uniwersyteckiego Szpitala Klinicznego nr 2.
Summary
Central pontine myelinolysis (CPM), a neurologic disorder, often arises from rapid correction of hyponatremia or nutritional deficits, particularly in chronic alcoholism. This case highlights CPM development in a patient with alcohol abuse and mild tetraparesis.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Central pontine myelinolysis (CPM) is a demyelinating neurologic disorder affecting the pons, characterized by axonal sparing and varied clinical presentations like locked-in syndrome or coma.
- Rapid correction of hyponatremia and nutritional deficiencies are recognized risk factors for CPM.
- Chronic alcoholism is frequently associated with CPM, appearing in over half of cases, often in late stages.
Observation:
- The authors present a case of a 31-year-old patient with a four-year history of alcohol abuse.
- This patient developed central pontine myelinolysis.
- The presenting symptom was mild tetraparesis.
Findings:
- The case study details the occurrence of CPM in an individual with a history of significant alcohol consumption.
- The patient exhibited mild tetraparesis as a clinical manifestation of CPM.
- This instance underscores the link between alcohol abuse and the development of central pontine myelinolysis.
Implications:
- This case reinforces the critical need for careful electrolyte management, especially in patients with alcoholism, to prevent iatrogenic CPM.
- Understanding the multifactorial etiology of CPM, including nutritional status and underlying conditions, is crucial for timely diagnosis and treatment.
- Further research into the specific mechanisms linking alcohol abuse and demyelination in CPM may reveal targeted therapeutic strategies.
